Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169572 per QALY and exenatide with $278935 per QALY as second-line treatment in adult diabetics in the USA

Wendy Davis

Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169572 per QALY and exenatide with $278935 per QALY as second-line treatment in adult diabetics in the USA

Research output: Contribution to journal › Review article

Original language	English
Pages (from-to)	40-41
Journal	Evidence - Based Medicine (English Edition): for primary care and internal medicine
Volume	15
Issue number	2
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{5defde77d5264ccb99d4d067c64a9ebf,

title = "Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169572 per QALY and exenatide with $278935 per QALY as second-line treatment in adult diabetics in the USA",

author = "Wendy Davis",

year = "2010",

language = "English",

volume = "15",

pages = "40--41",

journal = "Evidence - Based Medicine (English Edition): for primary care and internal medicine",

issn = "1356-5524",

publisher = "BMJ Publishing Group",

number = "2",

}

Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169572 per QALY and exenatide with $278935 per QALY as second-line treatment in adult diabetics in the USA. / Davis, Wendy.
In: Evidence - Based Medicine (English Edition): for primary care and internal medicine, Vol. 15, No. 2, 2010, p. 40-41.

Research output: Contribution to journal › Review article

TY - JOUR

T1 - Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169572 per QALY and exenatide with $278935 per QALY as second-line treatment in adult diabetics in the USA

AU - Davis, Wendy

PY - 2010

Y1 - 2010

M3 - Review article

SN - 1356-5524

VL - 15

SP - 40

EP - 41

JO - Evidence - Based Medicine (English Edition): for primary care and internal medicine

JF - Evidence - Based Medicine (English Edition): for primary care and internal medicine

IS - 2

ER -